Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 35 | $81,899,065 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Mar 2025 16:37 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 17 Mar 2025 | Sale | 2,500 | 110.53 | 276,325 | D |
| 12 Mar 2025 18:41 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 10 Mar 2025 | Sale | 4,916 | 117.2988 | 576,641 | D |
| 12 Mar 2025 18:41 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 10 Mar 2025 | Sale | 13,013 | 118.5011 | 1,542,055 | D |
| 19 Feb 2025 16:43 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 18 Feb 2025 | Sale | 2,500 | 104.09 | 260,225 | D |
| 13 Feb 2025 21:13 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 12 Feb 2025 | Sale | 137,676 | 102.22 | 14,073,241 | D |
| 03 Feb 2025 18:09 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 31 Jan 2025 | Sale | 142,180 | 97.22 | 13,822,740 | D |
| 16 Jan 2025 15:31 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 15 Jan 2025 | Sale | 2,500 | 91.35 | 228,375 | D |
| 17 Dec 2024 17:27 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 16 Dec 2024 | Sale | 8,500 | 91.96 | 781,660 | D |
| 03 Dec 2024 14:43 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 29 Nov 2024 | Sale | 120,715 | 92.7652 | 11,198,151 | D |
| 03 Dec 2024 14:43 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 29 Nov 2024 | Sale | 127,930 | 92.7626 | 11,867,119 | D |
| 29 Nov 2024 20:10 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 27 Nov 2024 | Sale | 57,294 | 91.7949 | 5,259,297 | D |
| 29 Nov 2024 20:10 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 27 Nov 2024 | Sale | 88,119 | 92 | 8,106,948 | D |
| 29 Nov 2024 20:10 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 27 Nov 2024 | Sale | 5,200 | 91.8041 | 477,381 | D |
| 29 Nov 2024 20:10 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 27 Nov 2024 | Sale | 3,199 | 91.8034 | 293,679 | D |
| 29 Nov 2024 20:10 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 27 Nov 2024 | Sale | 10,399 | 92 | 956,708 | D |
| 27 Nov 2024 18:14 | GILD | GILEAD SCIENCES Inc | BLUESTONE JEFFREY | Director | 26 Nov 2024 | Sale | 6,788 | 91.3901 | 620,356 | D |
| 07 Nov 2024 16:38 | GILD | GILEAD SCIENCES Inc | MERCIER JOHANNA | Chief Commercial Officer | 06 Nov 2024 | Sale | 5,000 | 91.28 | 456,400 | D |
| 07 Nov 2024 16:32 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 06 Nov 2024 | Sale | 20,590 | 91.5 | 1,883,985 | D |
| 07 Nov 2024 16:32 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 06 Nov 2024 | Sale | 5,000 | 91.5 | 457,500 | D |
| 02 Oct 2024 16:58 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 01 Oct 2024 | Sale | 2,000 | 83.83 | 167,660 | D |
| 13 Sep 2024 19:07 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 12 Sep 2024 | Sale | 21,246 | 84.5 | 1,795,287 | D |
| 13 Sep 2024 17:08 | GILD | GILEAD SCIENCES Inc | MERCIER JOHANNA | Chief Commercial Officer | 12 Sep 2024 | Sale | 13,432 | 83.25 | 1,118,214 | D |
| 13 Sep 2024 17:08 | GILD | GILEAD SCIENCES Inc | MERCIER JOHANNA | Chief Commercial Officer | 12 Sep 2024 | Sale | 15,925 | 84.23 | 1,341,363 | D |
| 29 Aug 2024 15:23 | GILD | GILEAD SCIENCES Inc | MERCIER JOHANNA | Chief Commercial Officer | 28 Aug 2024 | Sale | 9,513 | 78.03 | 742,299 | D |
| 14 Aug 2024 14:23 | GILD | GILEAD SCIENCES Inc | MERCIER JOHANNA | Chief Commercial Officer | 13 Aug 2024 | Sale | 5,490 | 73.98 | 406,150 | D |
| 01 Jul 2024 20:06 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 01 Jul 2024 | Sale | 2,000 | 68.63 | 137,260 | D |
| 02 Apr 2024 18:38 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 01 Apr 2024 | Sale | 2,000 | 72.96 | 145,920 | D |
| 29 Feb 2024 18:35 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 29 Feb 2024 | Sale | 8,230 | 72.7368 | 598,624 | D |
| 29 Feb 2024 18:35 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 28 Feb 2024 | Sale | 2,000 | 73.18 | 146,360 | D |
| 17 Jan 2024 18:01 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 16 Jan 2024 | Sale | 5,000 | 85.78 | 428,900 | D |
| 10 Jan 2024 15:58 | GILD | GILEAD SCIENCES Inc | MERCIER JOHANNA | Chief Commercial Officer | 09 Jan 2024 | Sale | 8,242 | 85.23 | 702,466 | D |
| 18 Oct 2023 16:31 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 17 Oct 2023 | Sale | 5,000 | 80.0034 | 400,017 | D |
| 13 Sep 2023 18:50 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 12 Sep 2023 | Sale | 1,501 | 76.99 | 115,562 | D |
| 21 Jul 2023 17:30 | GILD | GILEAD SCIENCES Inc | DICKINSON ANDREW D | Chief Financial Officer | 20 Jul 2023 | Sale | 5,000 | 80 | 400,000 | D |
| 14 Jun 2023 17:48 | GILD | GILEAD SCIENCES Inc | PARSEY MERDAD | Chief Medical Officer | 13 Jun 2023 | Sale | 1,485 | 76.9 | 114,197 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)